Jade Biosciences, Inc. Common Stock JBIO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -65.3%+45.4pp | -60.3%+26.6pp | -97.1%-44.9pp | -79.6%-31.9pp | -110.7%-39.6pp | |
| Liquidity | ||||||
| Current ratio | 14.3×-17.7× | 21.1×+15.3× | 9×+0.2× | 10.3×+3.8× | 32×+25.4× | |
| Quick ratio | 14.3×-17.7× | 21.1×+15.3× | 9×+0.2× | 10.3×+3.8× | 32×+25.4× | |
| Cash ratio | 2.5×-15.8× | 5.3×-0.4× | 2.2×-0.8× | 10.2×+8.4× | 18.3×+17.7× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | 0×— | 0×-681× | —— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -13×+21.4× | -14.6×+10.8× | -19.5×-1.9× | -25.5×-11.6× | -34.4×-20.3× | |
| Per Share | ||||||
| Book value per share | $5.13+119% | $10.60+171% | $4.53+185% | $7.09+2,363,000% | -$26.46-909% | |
| Valuation | ||||||
| Market capitalization | $1.33B+318% | $760.92M— | $281.57M— | $337.83M— | —— | |
| Enterprise value | $1.28B— | $673.33M— | $232.33M— | $117.7M— | —— | |
| Price / book | 4.5×— | 2.3×— | 1.6×— | 1.7×— | —— | |
| Earnings yield | -9.7%— | -16.7%— | -50.6%— | -39.5%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Jade Biosciences, Inc. Common Stock's ratios come from?
- Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.